Beta Bionics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $32,013 | $27,626 | $32,121 | $27,253 |
Gross Profit | 18,902 | 16,437 | 18,944 | 15,119 |
EBITDA | -24,460 | -21,224 | -12,530 | -13,526 |
EBIT | -25,578 | -21,895 | -13,465 | -14,209 |
Net Income | -23,403 | -21,895 | -13,466 | -14,209 |
Net Change In Cash | 32,013 | 27,626 | 32,121 | 27,253 |
Free Cash Flow | -15,661 | -25,209 | -10,530 | -10,011 |
Cash | 44,318 | 30,206 | 31,576 | 38,485 |
Basic Shares | 44,545 | 44,436 | 40,529 | 43,634 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $100,251 | $65,124 | $11,995 | $179 |
Gross Profit | 55,537 | 35,888 | 6,308 | 179 |
EBITDA | -70,324 | -53,605 | -42,873 | -63,399 |
EBIT | -73,199 | -54,756 | -44,099 | -64,744 |
Net Income | -73,200 | -54,756 | -44,099 | -64,751 |
Net Change In Cash | 100,251 | 65,124 | 11,995 | 179 |
Free Cash Flow | -56,222 | -51,668 | -32,847 | -60,980 |
Cash | 31,576 | 30,432 | 26,566 | 27,675 |
Basic Shares | 40,529 | 42,859 | 42,859 | 42,859 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.53 |
2026-03-31 | -$0.36 |
2025-12-31 | -$0.30 |
2025-09-30 | -$0.33 |